Health-related quality-of-life study in patients with carcinoma of the thyroid after thyroxine withdrawal for whole body scanning

Laryngoscope

Volumn 116, Issue 11, 2006, Pages 2060-2066

  Chow, Sin Ming ^a   Au, Kwok Hung ^a   Choy, Tim Shing ^a   Lee, Siu Hong ^a   Yeung, Nga Yan ^b   Leung, Angus ^a   Leung, Alex ^a   Leung, Hoi Leung ^a   Shek, Chi Chung ^a   Law, Stephen C K ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^b NONE

Author keywords

Chinese; FACT G questionnaire; Quality of life; Thyroxine withdrawal; Whole body scan

Indexed keywords

THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG WITHDRAWAL; EMOTION; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PHYSICAL CAPACITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; THYROID CARCINOMA; WHOLE BODY SCINTISCANNING;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, PAPILLARY; EMOTIONS; FEMALE; HONG KONG; HUMANS; HYPOTHYROIDISM; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; THYROID NEOPLASMS; THYROTROPIN; THYROXINE;

EID: 33750707987     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000240287.57704.01     Document Type: Article

References (18)

1. Chow SM. Role of radioactive iodine (I-131) in management of differentiated thyroid carcinoma. In: Milton CA, ed. Focus on Thyroid Cancer Research. New York: Nova Science Publishers, Inc; 2006.
2. Guidelines for the Management of Thyroid Cancer in Adults. British Thyroid Association and Royal College of Physicians of London; 2002.
3. Liel Y. Preparation for radioactive iodine administration in differentiated thyroid cancer patients. Clin Endocrinol (Oxf) 2002;57:523-527.
4. Harbert JC. Radioiodine Therapy of Differentiated Thyroid Carcinoma. In: Harbert JC, Eckelman WC, Neumann R, eds. Nuclear Medicine: Diagnosis and Therapy. New York: Thieme; 1996:975-1019.
5. Meier DA, Brill DR, Becker DV, et al. Procedure guideline for therapy of thyroid disease with (131)iodine. J Nucl Med 2002;43:856-861.
6. Pacini F, Ladenson PW, Schlumberger M, et al. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab 2006;91:926-932.
7. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570-579.
8. Yu CL, Fielding R, Chan CL, et al. Measuring quality of life of Chinese cancer patients: a validation of the Chinese version of the Functional Assessment of Cancer Therapy-General (FACT-G) scale. Cancer 2000;88:1715-1727.
9. Gulseren S, Gulseren L, Hekimsoy Z, et al. Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch Med Res 2006;37:133-139.
10. Botella-Carretero JI, Galan JM, Caballero C, et al. Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma. Endocr Relat Cancer 2003;10:601-610.
11. Schultz PN, Stava C, Vassilopoulou-Sellin R. Health profiles and quality of life of 518 survivors of thyroid cancer. Head Neck 2003;25:349-356.
12. Dagan T, Bedrin L, Horowitz Z, et al. Quality of life of well-differentiated thyroid carcinoma patients. J Laryngol Otol 2004;118:537-542.
13. Dow KH, Ferrell BR, Anello C. Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid 1997;7:613-619.
14. Crevenna R, Zettinig G, Keilani M, et al. Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy. Support Care Cancer 2003;9:597-603.
15. Davids T, Witterick IJ, Eski S, et al. Three-week thyroxine withdrawal: a thyroid-specific quality of life study. Laryngoscope 2006;116:250-253.
16. McMillan CV, Bradley C, Woodcock A, et al. Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism. Thyroid 2004;14:916-925.
17. Schroeder PR, Haugen BR, Pacini F, et al. A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal. J Clin Endocrinol Metab 2006;91:878-884.
18. Sanchez R, Espinosa-de-los-Monteros AL, Mendoza V, et al. Adequate thyroid-stimulating hormone levels after levothyroxine discontinuation in the follow-up of patients with well-differentiated thyroid carcinoma. Arch Med Res 2002;33:478-481.